Skip to main content
Foundation Updates

2021 Highlights and What’s Next

2021 Year in Review

In 2021, Parkinson’s research drove significant progress. Our Year in Review publication looks back on Parkinson’s breakthroughs and ahead to what’s coming in 2022 and beyond.

An important year for Parkinson’s research saw strides powered by our community — from discoveries in donor-funded lab studies to efforts expanding our understanding of the global impact of disease. These programs propel a robust and growing pipeline of new treatments closer to patient hands.

Our 2021 in Review and What's Next: Where the Power of Science Meets the Power of Community publication reviews findings and plans in the following areas:

  • Transforming the drug development landscape: What we’re tracking around alpha-synuclein, LRRK2, and other promising targets
  • Understanding the biology of Parkinson’s: The latest on our landmark Progression Markers Initiative (PPMI) to predict and prevent Parkinson’s 
  • Creating momentum with our community: MJFF’s work around increasing inclusiveness in Parkinson’s research

Read more in the review.

Doctor holding iPad with image of a brain scan.

Donate to Research

Your support moves us closer to a world without Parkinson's disease.

Donate Now
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.